|
Journal of Bioequivalence & Bioavailability |
What is Journal of Bioequivalence & Bioavailability (JBB) |
|
Journal of Bioequivalence & Bioavailability (JBB) open access is a peer reviewed, international, interdisciplinary scholarly open access journal of its field. JBB is one and only the open access journal in bioequivalence and bioavailability with academic support from leading research institutes and industries. JBB aims to provide evidence based force for the advancement of bioequivalence and bioavailability studies. An Open access online version of JBB is published by the OMICS Publishing Group, an international open access publisher for the advancement of Science & Technology. |
|
JBB publishes but not limited to, ethical issues involved in bioequivalence study, sample preparation for analysis, bioequivalence study and data interpretation, sample preparation techniques for bioanalysis, analytical methodology development for quantification drugs, HPLC and LC-MS/MS methodologies for quantification of drugs and pharmaceuticals in different body fluids, bioanalytical method validation and validation parameters, bioavailability reports in humans and animals, microdialysis and its applications in bioavailability, drug delivery and kinetic studies, pharmacokinetics, pharmacodynamics, systems clinical and toxicological analysis. |
|
What is Bioequivalence & Bioavailability? |
|
The patient consumes drugs such as tablets, capsules and liquids etc. to rescue from his/her illness. The main objective of any therapeutic is, it should reach the required therapeutic efficacy after being absorbed in blood. The main intention of the bioavailability study is to quantify the drug in blood plasma or other suitable medium with the help of advanced instrumentation such as liquid chromatography tandem mass spectrometry as per the guidelines of USFDA, European, Japan and other official organizations. Bioequivalence of a therapeutic is achieved if its extent and rate of absorption are not statistically significantly different from test therapeutic formulation put together by the certain company with a standard reference formulation of the same therapeutic (when both are administered with same molar dose). |
|
Why is new journal? |
|
JBB has founded to meet the demand and phenomenal growth of bioequivalence and bioavailability studies, and no journal is available under the titles of bioequivalence and bioavailability particularly under open access category. The main motto f the journal is to bring all scattered bioequivalence reports under one open access platform. Open access publication is the best solution for significant output and human endeavors. Under open access plat form, JBB is an adventurous venue to the scientists of its field and it will become treasure trove for the bioequivalence and bioavailability reports. To serve better for readers, authors, reviewers, and editors. JBB strives to ensure and publish best possible scientific outputs and published articles reaches thousands of audience by E-mail immediately upon publication. |
|
In today's wired world, information is available at the click of the button, courtesy the Internet. JBB -open access gives a worldwide audience larger than that of any subscription- based journal in the field of life sciences, no matter how prestigious or popular, and probably increases the visibility and impact of published work. JBB-open access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. JBB - open access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content. |
|
| • |
Papers published in JBB are peer reviewed will be referenced by cross referenced shortly. JBB will keep up to date with latest advances in the field and papers published in JBB will reach the readers directly by email for free of cost. |
| • |
Distributed widely through the Internet. |
| • |
Archived online in the transactions of the OMICS Publishing Group, which provides the international scientific community with immediate and permanent access to individual papers. |
|
| |
Open Access is a publication model that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under open access can be accessed by anyone with internet connection. JBB strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by JBB are freely accessible to everyone immediately after publication. |
|
| • |
All works published by OMICS Publishing Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited JBB supports the Bethesda Statement on Open Access Publishing. |
| |
Definition of Open Access Publication |
• |
An Open Access Publication is one that meets the following two conditions: |
1 |
The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use. |
2 |
A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository). |
| |
Notes: |
• |
Open access is a property of individual works! |
• |
Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now. |
|
| |
|
